Engineered iron oxide nanoplatforms: reprogramming immunosuppressive niches for precision cancer theranostics.

Yang C, Li S, Wang L

Open source

DOI: 10.1186/s12943-025-02443-2
Published: 2025 Sep 1
Container: Molecular cancer
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12943-025-02443-2,
  title = {Engineered iron oxide nanoplatforms: reprogramming immunosuppressive niches for precision cancer theranostics.},
  author = {Yang C and Li S and Wang L},
  year = {2025},
  journal = {Molecular cancer},
  doi = {10.1186/s12943-025-02443-2},
  url = {https://doi.org/10.1186/s12943-025-02443-2}
}

RIS

TY  - JOUR
TI  - Engineered iron oxide nanoplatforms: reprogramming immunosuppressive niches for precision cancer theranostics.
AU  - Yang C
AU  - Li S
AU  - Wang L
PY  - 2025
JO  - Molecular cancer
DO  - 10.1186/s12943-025-02443-2
UR  - https://doi.org/10.1186/s12943-025-02443-2
ER  -

APA

C, Y., S, L., & L, W. (2025). Engineered iron oxide nanoplatforms: reprogramming immunosuppressive niches for precision cancer theranostics.. Molecular cancer. https://doi.org/10.1186/s12943-025-02443-2

Source records

pubmed · retrieved 2026-09-25T07:50:47.827Z
europe-pmc · retrieved 2026-09-25T07:50:47.842Z
doaj · retrieved 2026-09-25T07:50:47.839Z